If the U.S. benchmarks Medicare drug prices to the lowest prices paid in other wealthy countries, what’s the most likely outcome?
Trump argues Americans shouldn’t pay more for the same medicines than other developed countries, and supports a “most-favored-nation” approach that would benchmark some U.S. drug prices to the lowest prices paid abroad. A similar MFN model was attempted previously but was blocked in court and later rescinded. (Also circulating: Trump’s claim he pressured foreign leaders on drug pricing—this portion is his account and not independently verified.)
Credit: @realnewsnobullshit (Instagram Reel)